Latest Management of Crohn's disease Stories
SGM-1019 is an oral small molecule inhibitor of a target identified by company's Microbiome Discovery Platform SOUTH SAN FRANCISCO, Jan.
Bacteria and Genes in Small Intestine affect course of IBD in Children NEW YORK, July 16, 2014 /PRNewswire-USNewswire/ -- Specific types of bacteria and accompanying gene expression
- The long-term safety profile was consistent with pivotal trials of Cimzia® ATLANTA, May 5, 2014 /PRNewswire/ -- UCB announced today results from the PRECiSE 3 7-year open label extension
CoolCell® cell freezing device and CoolBox(TM) ice-free cooling workstations chosen to support handling and processing of investigational cell therapy product in landmark clinical research trial.
More people are being affected by drug-induced liver injury (DILI) than ever before.
The drug natalizumab is effective for treating multiple sclerosis (MS), but it increases the risk of a rare but potentially fatal brain infection called progressive multifocal leukoencephalopathy (PML).
- A volcanic mudflow.